GNPDA2 and amyotrophic lateral sclerosis: We found that GNPDA2 serum levels were commonly increased across all indicated disorders with respect to the control population, and sex-independent in LBD, PSP, DFT and ALS patients and in control subjects (Figure 7B, Supplementary Figure S3).